{"id":"W3216161881","doi":"10.1158/1535-7163.mct-21-0411","title":"Cyclin-dependent Kinase 4/6 Inhibitor Palbociclib in Combination with Ralaniten Analogs for the Treatment of Androgen Receptor–positive Prostate and Breast Cancers","year":2021,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Palbociclib; Prostate; Androgen receptor; Medicine; Cyclin-dependent kinase 4; Internal medicine; Kinase; Cancer research; Androgen; Oncology; Endocrinology; Prostate cancer; Pharmacology; Breast cancer; Biology; Cancer; Cyclin-dependent kinase 2; Hormone; Cell cycle; Metastatic breast cancer; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007491426,0.0002278678,0.0003617259,0.00006668654,0.00006876171,0.00001922879,0.00005426927,0.00006852127,0.00001392384],"category_scores_gemma":[0.00000316449,0.0001564942,0.00007772942,0.0002763404,0.0001712339,0.00005491212,0.00001424889,0.00009330179,2.888731e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005739084,"about_ca_system_score_gemma":0.0004183214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003282725,"about_ca_topic_score_gemma":0.00056559,"domain_scores_codex":[0.9988508,0.00006384664,0.0002491223,0.0003349704,0.0002369536,0.0002643063],"domain_scores_gemma":[0.9991388,0.00008333381,0.0001419536,0.000266662,0.0003016198,0.00006765788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.009864077,0.001179825,0.06391148,0.0002502628,0.002729218,0.0002004025,0.008954732,0.001468615,0.2903396,0.0003933416,0.000007942755,0.6207005],"study_design_scores_gemma":[0.03319822,0.003910451,0.03355457,0.0007119605,0.00138323,0.0002245995,0.003205024,0.001312797,0.9066275,0.0007092155,0.01456174,0.0006007402],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9643937,0.02747552,0.002238449,0.003760932,0.0001199588,0.00159016,0.0003721449,0.00002275998,0.00002631616],"genre_scores_gemma":[0.9924076,0.005051515,0.0008475496,0.0008254615,0.00005994335,0.0005023415,0.00009767144,0.00005682745,0.0001510676],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6200998,"threshold_uncertainty_score":0.6381648,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01421695393868247,"score_gpt":0.2829275605301325,"score_spread":0.2687106065914501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}